% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

  • dev_eng_mb dev_eng_mb Sep 26, 2012 11:19 AM Flag


    Not sure VRTX deserves the downtrend over that last couple of days. They are advancing 1 of 2 nucs that they invested in towards HCV. Currently they own the latest effective Tx for the disease (Incivek). Back in the day when VRTX was advancing VX950 (Incivek) in clinical trials for approval and MRK and GILD showed up as competitors, the street drove VRTX down because VX950 now had "competition". Now that VRTX (w/Incivek) is advancing a competitive nuc, why is it the street is driving VRTX down and GILD up?
    Am I trying to make sense of something that in reality will never make sense? 1 step forward, 2 steps back.
    JMHO. Good luck to all!!!

    SortNewest  |  Oldest  |  Most Replied Expand all replies
100.99+0.03(+0.03%)Aug 23 4:00 PMEDT